Related Experiment Videos
Ketotifen in African children
International Journal of Clinical Pharmacology Research
|January 1, 1983
Summary
Ketotifen, an oral asthma medication, effectively reduced the frequency and severity of asthma attacks in children over three months. This prophylactic drug also decreased the need for bronchodilator use with minimal side effects.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Childhood asthma represents a significant public health concern.
- Effective prophylactic treatments are crucial for managing pediatric asthma exacerbations.
Purpose of the Study:
- To evaluate the efficacy of ketotifen as an oral prophylactic agent in asthmatic children.
- To assess the impact of ketotifen on asthma attack frequency, severity, and bronchodilator usage.
Main Methods:
- A cohort of 26 children diagnosed with asthma (mean age 4.9 years) received ketotifen.
- Treatment outcomes were monitored over a three-month period.
Main Results:
- Ketotifen significantly reduced the number and severity of acute asthmatic attacks.
- Concomitant use of bronchodilators decreased during the study period.
- Minimal adverse effects were reported in the pediatric participants.
Conclusions:
- Ketotifen demonstrates beneficial effects in the management of childhood asthma.
- The oral prophylactic drug offers a promising therapeutic option for pediatric asthma patients.